ALTSHULER DAVID 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 19, 2025
Insider Transaction Report
Form 4
ALTSHULER DAVID
EVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-05-15$424.69/sh−52$22,084→ 23,281 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.